These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian epithelial cancer AND MUC16, CA125, CA-125 AND Diagnosis
508 results:

  • 1. The application value of two-dimensional ultrasound combined with contrast-enhanced ultrasound in the differential diagnosis of benign, borderline, and malignant ovarian epithelial tumors.
    Wang R; Liu H; Tang J; Geng J
    J Ovarian Res; 2024 Sep; 17(1):191. PubMed ID: 39342318
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients.
    Attianese D; Massobrio R; Giorgi M; Villa M; Fuso L; Badellino E; Bellero M; Ferrero A
    Arch Gynecol Obstet; 2024 Oct; 310(4):2183-2190. PubMed ID: 39093333
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The effect of tinzaparin on biomarkers in FIGO stages III-IV ovarian cancer patients undergoing neoadjuvant chemotherapy - the TABANETOC trial: study protocol for a randomized clinical multicenter trial.
    Karlsson A; Lindahl G; Spetz Holm AC; Bergmark K; Dahm Kähler P; Fekete B; Ottander U; Öfverman C; Israelsson P; Falknäs L; Rosenmüller A; Tiefenthal Thrane M; Halili S; Lindahl TL; Jenmalm MC; Kjølhede P
    Acta Oncol; 2024 Jul; 63():581-585. PubMed ID: 39037076
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Preoperative neutrophil/lymphocyte ratio as prognostic factor in epithelial ovarian cancer.
    Vázquez Rojo J; Vázquez Reguera J; Sánchez del Río A
    Rev Colomb Obstet Ginecol; 2024 Mar; 75(1):. PubMed ID: 39013201
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation of the Cutoff Point and Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio in Predicting ovarian cancer Compared to Pathological Findings.
    Hosseini MS; Amiri F; Rezapour M; Ashraf Ganjoie T; Farzaneh F; Arab M; Talayeh M; Beheshti Rooy R; Hadi F
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):971-976. PubMed ID: 38546079
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diagnostic value of plasma-derived exosomal miR-223 for epithelial ovarian cancer.
    Yang L; Yang Z; Liu Z; Qi N; Tao L
    BMC Womens Health; 2024 Mar; 24(1):150. PubMed ID: 38431592
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass.
    Gaillard DHK; Lof P; Sistermans EA; Mokveld T; Horlings HM; Mom CH; Reinders MJT; Amant F; van den Broek D; Wessels LFA; Lok CAR; ;
    Int J Gynecol Cancer; 2024 May; 34(5):713-721. PubMed ID: 38388177
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ovarian clear cell carcinoma with uterine intramural recurrence: Case report of ovarian clear cell carcinoma with fertility sparing treatment.
    Chang TY; Yeh CY; Yang CY; Lin WC; Huang CC; Hung YC
    Taiwan J Obstet Gynecol; 2024 Jan; 63(1):90-94. PubMed ID: 38216278
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I ca125 and anti-ca125.
    Yang ST; Chang WH; Chou FW; Liu HH; Lee WL; Wang PH
    Taiwan J Obstet Gynecol; 2023 Nov; 62(6):802-808. PubMed ID: 38008497
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. miR-29c-3p acts as a tumor promoter by regulating β-catenin signaling through suppressing DNMT3A, TET1 and HBP1 in ovarian carcinoma.
    Zhao H; Feng L; Cheng R; Wu M; Bai X; Fan L; Liu Y
    Cell Signal; 2024 Jan; 113():110936. PubMed ID: 37925048
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer.
    Shan D; Cheng S; Ma Y; Peng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1039-1049. PubMed ID: 37724407
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnostic value of ca125, HE4, and systemic immune-inflammation index in the preoperative investigation of ovarian masses.
    Song L; Qi J; Zhao J; Bai S; Wu Q; Xu R
    Medicine (Baltimore); 2023 Sep; 102(37):e35240. PubMed ID: 37713838
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [
    Chen J; Xu K; Li C; Tian Y; Li L; Wen B; He C; Cai H; He Y
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4064-4076. PubMed ID: 37526694
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The performance of Carbohydrate Antigen 125-Thomsen-nouveau and anti-Müllerian hormone combined with ca125, Human epididymis protein 4 and Risk of Malignancy Algorithm in diagnosis for patients with epithelial ovarian cancer.
    Hou X; Liu S; Liu J; Zhou J; Liang Y; Cui L
    Clin Biochem; 2023 Sep; 119():110615. PubMed ID: 37517433
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. An analysis of clinical characteristics and prognosis of endometrioid ovarian cancer based on the SEER database and two centers in China.
    Chen S; Lu H; Jiang S; Li M; Weng H; Zhu J; Zhang T; Wang Y; Zhao W; Wu D; Shen Z; Yang Z; Zhou Y
    BMC Cancer; 2023 Jul; 23(1):608. PubMed ID: 37391693
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Seeing beyond the tumor: computed tomography image-based radiomic analysis helps identify ovarian clear cell carcinoma subtype in epithelial ovarian cancer.
    Ren J; Mao L; Zhao J; Li XL; Wang C; Liu XY; Jin ZY; He YL; Li Y; Xue HD
    Radiol Med; 2023 Aug; 128(8):900-911. PubMed ID: 37368228
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.
    Lu R; Tang P; Zhang D; Lin S; Li H; Feng X; Sun M; Zhang H
    Pathol Res Pract; 2023 Aug; 248():154602. PubMed ID: 37315400
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer.
    Kus F; Guven DC; Yildirim HC; Chalabiyev E; Akyildiz A; Tatar OD; Sahin YB; Ileri S; Karaca E; Kertmen N; Arik Z
    Biomark Med; 2023 Apr; 17(7):379-389. PubMed ID: 37309756
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Improving SERS biosensors for the analysis of ovarian cancer-derived small extracellular vesicles.
    Ngo L; Zhang W; Hnit SST; Wang Y
    Analyst; 2023 Jun; 148(13):3074-3086. PubMed ID: 37306655
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical value of serum and tissue AGR2 for diagnosis and prognosis in epithelial ovarian cancer.
    Yan T; Wang H; Ma X; Cao J; Tong Y; Guo L; Lu R
    Biomark Med; 2023 Mar; 17(6):325-336. PubMed ID: 37284743
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 26.